Risk of leukemia following treatment for non-Hodgkin's lymphoma.

Travis, L B; Curtis, R E; Stovall, M; Holowaty, E J; van Leeuwen, F E; Glimelius, B; Lynch, C F; Hagenbeek, A; Li, C Y; Banks, P M

Travis, L B; Curtis, R E; Stovall, M; Holowaty, E J; van Leeuwen, F E; Glimelius, B; Lynch, C F; Hagenbeek, A; Li, C Y; Banks, P M.

Affiliation

Travis LB; Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Md 20892.

J Natl Cancer Inst ; 86(19): 1450-7, 1994 Oct 05.

Article in En | MEDLINE | ID: mdl-8089863

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/adverse effects; Leukemia, Myeloid, Acute/etiology; Leukemia, Radiation-Induced/etiology; Lymphoma, Non-Hodgkin/therapy; Neoplasms, Second Primary/chemically induced; Aged; Case-Control Studies; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Leukemia, Myeloid, Acute/chemically induced; Logistic Models; Lymphoma, Non-Hodgkin/drug therapy; Lymphoma, Non-Hodgkin/radiotherapy; Male; Middle Aged; Radiotherapy/adverse effects; Registries

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Leukemia, Myeloid, Acute / Leukemia, Radiation-Induced / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Second Primary Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1994 Type: Article

Search on Google

XML

PubMed Links